Rafael Ponce

Affiliate Associate Professor, Env. and Occ. Health Sciences (Primary department)
Dr. Ponce is a Scientific Director in the Comparative Biology and Safety Assessment group at Amgen (Seattle, WA). Prior to this position he was Director of Preclinical Safety Assessment at ZymoGenetics, Inc. (Seattle, Washington). He has previously worked as a research toxicologist at SNBL USA and the University of Washington, and as a toxicologist for the Alaska Department of Health and Social Services. Dr. Ponce is a Diplomate of the American Board of Toxicology.

Research Interests

  • Current research focus: The development of immunotherapies in the treatment of cancer, and the immunogenicity of biotherapeutic drugs.

Teaching interests

Toxicology and biotherapeutic drug development, mercury and neurodevelopment

Projects

Immunomodulation and cancer in nonclinical species and humans
Review date: 
12/10/2017